Vivos Therapeutics, Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
Vivos Therapeutics, Inc. (VVOS) had Stock Issued During Period, Value, Restricted Stock Award, Gross of $1.50 million as of 2025-06-10, per its 10-Q filed 2025-08-19.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross · last filed 2025-08-19
- 2025-06-10: Stock Issued During Period, Value, Restricted Stock Award, Gross $1.50M.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross |
|---|---|
| 2025-06-10 | $1.50M 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |